Quara Devices is introducing its new CEO, Steven Eror, to select investors during the JP Morgan Biotechnology Week in San Francisco
Back to Newsroom
Mentioned in this Article

Quara Devices is introducing its new CEO, Steven Eror, to select investors during the JP Morgan Biotechnology Week in San Francisco

Thursday, January 9, 2020 9:05 AM
Share this article now
Topic:
Conferences

SAN FRANCISCO, CA / ACCESSWIRE / January 9, 2020 / Quara Devices Inc, is a privately held company with an entirely new technology platform that measures the signature of infectious bacteria, enabling real-time and rapid response in medical, veterinary, pharmaceutical and aquatic applications. Quara Devices is introducing its new CEO, Steven Eror, to select investors at the JP Morgan Biotechnology week in San Francisco. Mr. Eror and his team are developing and commercializing the world's first Pathogenometer™, QuaraSense™, and its companion product, QuaraView™.

To view the full release with downloadable visuals and more, click here.

About the Company

Quara is a private US company launching a novel, proprietary technology platform for human health, animal health, biotechnology and food processing industries. Its technology is rapid, accurate and handheld and features the QuaraSense and QuaraView product opportunities. Read more HERE.

Quara will also be presenting its Reg D private investment opportunity to selected investors. Click HERE for more information.

Contact

Steven Eror
[email protected]
801-631-7288
Chief Executive Officer

SOURCE: Quara

Quara
$0.0000
$0.0000
Back to Newsroom
Copyright 2020 © ACCESSWIRE. All rights reserved. Privacy Policy  |  Terms and Conditions
Drop us a line: